MetaADEDB 2.0 @ LMMD
telaprevir
(BBAWEDCPNXPBQM-GDEBMMAJSA-N)
Structure
SMILES
CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C1CCCCC1)NC(=O)c1nccnc1
Type(s)
Approved; Withdrawn
ATC code(s)
J05AP02
Molecular Formula:
C36H53N7O6
Molecular Weight:
679.849
Log P:
3.9474
Hydrogen Bond Acceptor:
13
Hydrogen Bond Donor:
4
TPSA:
179.56
CAS Number(s):
402957-28-2
Synonym(s)
1.
telaprevir
2.
VX 950
3.
VX-950
4.
VX950 cpd
5.
incivek
External Link(s)
MeSHC486464
PubChem Compound3010818
BindingDB50326056
ChEBI68595
CHEMBLCHEMBL231813
DrugBankDB05521
DrugCentral4173
IUPHAR/BPS Guide to PHARMACOLOGY7871
KEGGdr:D09012
Therapeutic Target DatabaseD0X9CH
D07ZAH
ZINC3992480
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 176
Canada Vigilance: 1
Canada Vigilance
US FAERS
2FatigueFAERS: 138
Canada Vigilance: 1
Canada Vigilance
US FAERS
3PruritusFAERS: 120US FAERS
4VomitingFAERS: 110US FAERS
5Adverse eventFAERS: 95US FAERS
6Anorectal discomfortFAERS: 72US FAERS
7AstheniaFAERS: 51US FAERS
8HeadacheFAERS: 42US FAERS
9Drug ineffectiveFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
10NeutropeniaFAERS: 35US FAERS
11Weight decreasedFAERS: 30US FAERS
12Blood creatinine increasedFAERS: 29US FAERS
13DizzinessFAERS: 27US FAERS
14DysgeusiaFAERS: 26US FAERS
15Skin reactionFAERS: 26US FAERS
16Drug dose omissionFAERS: 23US FAERS
17AlopeciaFAERS: 20US FAERS
18MalaiseFAERS: 20US FAERS
19PainFAERS: 19US FAERS
20White blood cell count decreasedFAERS: 19US FAERS
21ThrombocytopeniaFAERS: 18US FAERS
22DermatitisFAERS: 17US FAERS
23InfectionFAERS: 16US FAERS
24SepsisFAERS: 16US FAERS
25Unevaluable eventFAERS: 16US FAERS
26UrticariaFAERS: 16US FAERS
27RestlessnessFAERS: 15US FAERS
28PancytopeniaFAERS: 14US FAERS
29AnxietyFAERS: 13US FAERS
30Stevens-Johnson SyndromeFAERS: 1325811541CTD
US FAERS
31Dry skinFAERS: 12US FAERS
32HypersensitivityFAERS: 11US FAERS
33Rash erythematousFAERS: 11US FAERS
34Abdominal PainFAERS: 10US FAERS
35ArthralgiaFAERS: 10US FAERS
36DyspepsiaFAERS: 10US FAERS
37PneumoniaFAERS: 10US FAERS
38TremorFAERS: 10US FAERS
39Visual ImpairmentFAERS: 10US FAERS
40Irritable Bowel SyndromeFAERS: 9US FAERS
41PancreatitisFAERS: 9US FAERS
42StomatitisFAERS: 9US FAERS
43SyncopeFAERS: 9US FAERS
44Chest PainFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
45DehydrationFAERS: 8US FAERS
46Feeling abnormalFAERS: 8US FAERS
47Musculoskeletal PainFAERS: 8US FAERS
48MyalgiaFAERS: 8US FAERS
49ChillsFAERS: 7US FAERS
50Erythema MultiformeFAERS: 7US FAERS
51Hepatitis CFAERS: 718285474
26052383
CTD
US FAERS
52AscitesFAERS: 6US FAERS
53Blood count abnormalFAERS: 6US FAERS
54Blood potassium decreasedFAERS: 6US FAERS
55Emotional disorderFAERS: 6US FAERS
56EpistaxisFAERS: 6US FAERS
57Incorrect dose administeredFAERS: 6US FAERS
58LethargyFAERS: 6US FAERS
59LeukopeniaFAERS: 6US FAERS
60Mood swingsFAERS: 6US FAERS
61Myocardial InfarctionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
62Skin lesionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
63Abdominal discomfortFAERS: 5US FAERS
64ConstipationFAERS: 5US FAERS
65EczemaFAERS: 5US FAERS
66ErythemaFAERS: 5US FAERS
67Inappropriate schedule of drug administrationFAERS: 5US FAERS
68SwellingFAERS: 5US FAERS
69Urinary tract infectionFAERS: 5US FAERS
70Viral load increasedFAERS: 5US FAERS
71AbscessFAERS: 4US FAERS
72AsthmaFAERS: 4US FAERS
73CellulitisFAERS: 4US FAERS
74Depressed moodFAERS: 4US FAERS
75DysuriaFAERS: 4US FAERS
76EosinophiliaFAERS: 4US FAERS
77Intentional drug misuseFAERS: 4US FAERS
78Skin UlcerFAERS: 4US FAERS
79treatment failureFAERS: 4US FAERS
80Ammonia increasedFAERS: 3US FAERS
81Anal abscessFAERS: 3US FAERS
82Back PainFAERS: 3US FAERS
83Blood cholesterol increasedFAERS: 3US FAERS
84Blood creatine phosphokinase increasedFAERS: 3US FAERS
85Blood sodium decreasedFAERS: 3US FAERS
86Blood urea increasedFAERS: 3US FAERS
87Blood urine presentFAERS: 3US FAERS
88Cold sweatFAERS: 3US FAERS
89Creatinine renal clearance increasedFAERS: 3US FAERS
90Diabetes MellitusFAERS: 3US FAERS
91Drug dispensing errorFAERS: 3US FAERS
92Full blood count decreasedFAERS: 3US FAERS
93Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
94GoutFAERS: 3US FAERS
95Hepatic EncephalopathyFAERS: 3US FAERS
96Injection Site ReactionFAERS: 3US FAERS
97Intestinal ObstructionFAERS: 3US FAERS
98Medication ErrorFAERS: 3US FAERS
99Memory impairmentFAERS: 3US FAERS
100PanophthalmitisFAERS: 3US FAERS
101PsoriasisFAERS: 3US FAERS
102Quality of life decreasedFAERS: 3US FAERS
103Respiratory FailureFAERS: 3US FAERS
104Skin toxicityFAERS: 3US FAERS
105Toxic Epidermal NecrolysisFAERS: 3US FAERS
106UlcerFAERS: 3US FAERS
107VasculitisFAERS: 3US FAERS
108AbasiaFAERS: 2US FAERS
109AcneFAERS: 2US FAERS
110Alanine Aminotransferase IncreasedFAERS: 2US FAERS
111AmnesiaFAERS: 2US FAERS
112Anal FissureFAERS: 2US FAERS
113ApathyFAERS: 2US FAERS
114AphagiaFAERS: 2US FAERS
115Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
116Atrial FibrillationFAERS: 2US FAERS
117Blood potassium abnormalFAERS: 2US FAERS
118Burning sensationFAERS: 2US FAERS
119Cerebrovascular accidentFAERS: 2US FAERS
120CholelithiasisFAERS: 2US FAERS
121Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
122ColitisFAERS: 2US FAERS
123CystitisFAERS: 2US FAERS
124DiscomfortFAERS: 2US FAERS
125Drug prescribing errorFAERS: 2US FAERS
126Eosinophil percentage increasedFAERS: 2US FAERS
127EructationFAERS: 2US FAERS
128ExcoriationFAERS: 2US FAERS
129Exfoliative rashFAERS: 2US FAERS
130Eye painFAERS: 2US FAERS
131HypotensionFAERS: 2US FAERS
132HypothyroidismFAERS: 2US FAERS
133Impaired work abilityFAERS: 2US FAERS
134Incorrect drug administration durationFAERS: 2US FAERS
135Incorrect drug dosage form administeredFAERS: 2US FAERS
136Leukocytoclastic vasculitisFAERS: 2US FAERS
137Lipase increasedFAERS: 2US FAERS
138Lower respiratory tract infectionFAERS: 2US FAERS
139Neutrophil count decreasedFAERS: 2US FAERS
140Oropharyngeal painFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
141OverdoseFAERS: 2US FAERS
142PeritonitisFAERS: 2US FAERS
143Psychiatric symptomFAERS: 2US FAERS
144Pulmonary EmbolismFAERS: 2US FAERS
145PurpuraFAERS: 2US FAERS
146Rehabilitation therapyFAERS: 2US FAERS
147RetchingFAERS: 2US FAERS
148ScabFAERS: 2US FAERS
149Subcutaneous AbscessFAERS: 2US FAERS
150Superinfection bacterialFAERS: 2US FAERS
151Tongue blisteringFAERS: 2US FAERS
152ToothacheFAERS: 2US FAERS
153Transaminases increasedFAERS: 2US FAERS
154VertigoFAERS: 2US FAERS
155jaundiceFAERS: 2US FAERS
156Accidental exposure to product by childFAERS: 1US FAERS
157Administration site rashFAERS: 1US FAERS
158AgitationFAERS: 1US FAERS
159AkathisiaFAERS: 1US FAERS
160Alanine aminotransferase abnormalFAERS: 1US FAERS
161Anal FistulaFAERS: 1US FAERS
162Angina PectorisFAERS: 1US FAERS
163AnhidrosisFAERS: 1US FAERS
164Ankle FractureFAERS: 1US FAERS
165AnosmiaFAERS: 1US FAERS
166Aphthous StomatitisFAERS: 1US FAERS
167Aquagenic pruritusFAERS: 1US FAERS
168ArthritisFAERS: 1US FAERS
169Aspartate aminotransferase abnormalFAERS: 1US FAERS
170Auricular swellingFAERS: 1US FAERS
171BedriddenFAERS: 1US FAERS
172Biliary ColicFAERS: 1US FAERS
173Blood albumin abnormalFAERS: 1US FAERS
174Blood albumin increasedFAERS: 1US FAERS
175Blood alkaline phosphatase increasedFAERS: 1US FAERS
176Blood glucose decreasedFAERS: 1US FAERS
177Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
178Blood triglycerides increasedFAERS: 1US FAERS
179Blood uric acid decreasedFAERS: 1US FAERS
180Blood uric acidFAERS: 1US FAERS
181Bowel movement irregularityFAERS: 1US FAERS
182Brain AbscessFAERS: 1US FAERS
183Breast tendernessFAERS: 1US FAERS
184BronchitisFAERS: 1US FAERS
185CachexiaFAERS: 1US FAERS
186Chest discomfortFAERS: 1US FAERS
187ChokingFAERS: 1US FAERS
188Clostridium difficile colitisFAERS: 1US FAERS
189Corneal OpacityFAERS: 1US FAERS
190CryingFAERS: 1US FAERS
191CystFAERS: 1US FAERS
192DeafnessFAERS: 1US FAERS
193Deep Vein ThrombosisFAERS: 1US FAERS
194DeliriumFAERS: 1US FAERS
195Dental cariesFAERS: 1US FAERS
196Diabetes mellitus inadequate controlFAERS: 1US FAERS
197DisabilityFAERS: 1US FAERS
198DiverticulitisFAERS: 1US FAERS
199Drug administration errorFAERS: 1US FAERS
200Drug effect incompleteFAERS: 1US FAERS
201Drug withdrawal syndromeFAERS: 1US FAERS
202DysarthriaFAERS: 1US FAERS
203DysphoniaFAERS: 1US FAERS
204Emotional distressFAERS: 1US FAERS
205EncephalitisFAERS: 1US FAERS
206EndocarditisFAERS: 1US FAERS
207Expired drug administeredFAERS: 1US FAERS
208Febrile NeutropeniaFAERS: 1US FAERS
209FlatulenceFAERS: 1US FAERS
210Gas PoisoningFAERS: 1US FAERS
211GastroenteritisFAERS: 1US FAERS
212GingivitisFAERS: 1US FAERS
213HaematotoxicityFAERS: 1US FAERS
214Hepatic cancer stage IIFAERS: 1US FAERS
215Hepatitis BFAERS: 1US FAERS
216HepatitisFAERS: 1US FAERS
217HypersomniaFAERS: 1US FAERS
218HypophagiaFAERS: 1US FAERS
219HypoxiaFAERS: 1US FAERS
220ImpatienceFAERS: 1US FAERS
221Incorrect storage of drugFAERS: 1US FAERS
222Initial insomniaFAERS: 1US FAERS
223Joint swellingFAERS: 1US FAERS
224Klebsiella test positiveFAERS: 1US FAERS
225Laboratory test interferenceFAERS: 1US FAERS
226Limb injuryFAERS: 1US FAERS
227Limb operationFAERS: 1US FAERS
228Lip swellingFAERS: 1US FAERS
229LymphadenopathyFAERS: 1US FAERS
230Lymphocyte count decreasedFAERS: 1US FAERS
231LymphomaFAERS: 1US FAERS
232LymphopeniaFAERS: 1US FAERS
233MalnutritionFAERS: 1US FAERS
234MenorrhagiaFAERS: 1US FAERS
235Multi-organ disorderFAERS: 1US FAERS
236Muscle abscessFAERS: 1US FAERS
237Musculoskeletal chest painFAERS: 1US FAERS
238MyositisFAERS: 1US FAERS
239Nasal discomfortFAERS: 1US FAERS
240NephrolithiasisFAERS: 1US FAERS
241Night sweatsFAERS: 1US FAERS
242Nonspecific reactionFAERS: 1US FAERS
243Oral candidiasisFAERS: 1US FAERS
244Oral mucosal eruptionFAERS: 1US FAERS
245Oropharyngeal blisteringFAERS: 1US FAERS
246Oropharyngeal candidiasisFAERS: 1US FAERS
247PallorFAERS: 1US FAERS
248PapuleFAERS: 1US FAERS
249ParanoiaFAERS: 1US FAERS
250Penile size reducedFAERS: 1US FAERS
251Pericardial effusionFAERS: 1US FAERS
252PericarditisFAERS: 1US FAERS
253Personality ChangeFAERS: 1US FAERS
254PoisoningFAERS: 1US FAERS
255Poor quality drug administeredFAERS: 1US FAERS
256Poor quality sleepFAERS: 1US FAERS
257Portal Vein ThrombosisFAERS: 1US FAERS
258Post-Traumatic Stress DisorderFAERS: 1US FAERS
259Potentiating drug interactionFAERS: 1US FAERS
260PresyncopeFAERS: 1US FAERS
261Procedural site reactionFAERS: 1US FAERS
262Product packaging issueFAERS: 1US FAERS
263Product size issueFAERS: 1US FAERS
264PurulenceFAERS: 1US FAERS
265Rectal dischargeFAERS: 1US FAERS
266Renal abscessFAERS: 1US FAERS
267Renal tubular necrosisFAERS: 1US FAERS
268Retinal DetachmentFAERS: 1US FAERS
269RetinitisFAERS: 1US FAERS
270Rheumatoid ArthritisFAERS: 1US FAERS
271SciaticaFAERS: 1US FAERS
272Sense of oppressionFAERS: 1US FAERS
273Septic ShockFAERS: 1US FAERS
274Sinus headacheFAERS: 1US FAERS
275SinusitisFAERS: 1US FAERS
276Sjogren's SyndromeFAERS: 1US FAERS
277Skin necrosisFAERS: 1US FAERS
278SomnolenceFAERS: 1US FAERS
279Staphylococcus test positiveFAERS: 1US FAERS
280Suicide attemptFAERS: 1US FAERS
281Supraventricular tachycardiaFAERS: 1US FAERS
282Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
283ThirstFAERS: 1US FAERS
284ThrombosisFAERS: 1US FAERS
285Tooth LossFAERS: 1US FAERS
286Toxicity to various agentsFAERS: 1US FAERS
287TuberculosisFAERS: 1US FAERS
288Urate nephropathyFAERS: 1US FAERS
289Virologic failureFAERS: 1US FAERS
290Vital functions abnormalFAERS: 1US FAERS
291Vitreous floatersFAERS: 1US FAERS
292Vulvovaginal pruritusFAERS: 1US FAERS
293WheezingFAERS: 1US FAERS
294White blood cell count abnormalFAERS: 1US FAERS
295Wound InfectionFAERS: 1US FAERS
296Wrong technique in drug usage processFAERS: 1US FAERS
297furuncleFAERS: 1US FAERS
298Hepatitis C, Chronic24927617CTD
299Rhabdomyolysis24927617CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.